Musa Jonah, Adamu Ibrahim S, Muhammad Zakari, Egbodo Christopher, Mohammed Caleb
Department of Obstetrics and Gynecology, Jos University Teaching Hospital, Jos, Nigeria.
Niger J Med. 2012 Apr-Jun;21(2):185-9.
Gynecologists being the primary care physicians and advocates for women sexual and reproductive health are critical in delivering messages on effective intervention to prevent heterosexual HIV transmission. Their knowledge and opinions on the effectiveness of HIV prevention technologies may influence the acceptance and use of these technologies among women at risk.
A cross sectional survey was self-administered to Nigerian gynecologist attending an Annual Scientific conference; "Kanon Dabo" between November 17 and 21, 2009, in Kano, Nigeria. Their opinions on various HIV prevention strategies as well as their willingness to collaborate on vaginal microbicides trials were assessed on a Likert scale. The mean scores of the responses were tested using student's T-test. Statistical analyses were done with STATA version 11, College Station, Texas, USA.
Of the 100 questionnaires distributed to the participants at the conference, we had a survey response rate of 74.0%. The mean age of the participants was 42.38 +/- 6.67 years with range 30-58 years. Male participants constituted 84.9%, and Female participants 15.1%. Twenty five percent (25%) of the surveyed participants were aware of vaginal microbicides, and only 3% correctly mentioned an example of a vaginal microbicide for HIV prevention. The willingness of the participants to collaborate on vaginal microbicides trials was not significantly related to their knowledge on vaginal microbicides (p = 0.475).
We concluded that the current knowledge of Nigerian gynecologist on vaginal microbicides is poor. Efforts to create awareness among these women advocates on recent HIV prevention technology, particularly, vaginal microbicides are required.
妇科医生作为女性性健康和生殖健康的初级保健医生及倡导者，在传递有效干预措施以预防异性间HIV传播的信息方面至关重要。他们对HIV预防技术有效性的知识和观点可能会影响高危女性对这些技术的接受和使用。
2009年11月17日至21日在尼日利亚卡诺举行的“卡农·达博”年度科学会议上，对参会的尼日利亚妇科医生进行了一项横断面自我管理调查。使用李克特量表评估了他们对各种HIV预防策略的看法以及他们参与阴道微生态制剂试验合作的意愿。使用学生t检验对回答的平均分数进行了测试。使用美国得克萨斯州大学站市的STATA 11版进行统计分析。
在会议上向参与者发放的100份问卷中，我们的调查回复率为74.0%。参与者的平均年龄为42.38±6.67岁，年龄范围为30至58岁。男性参与者占84.9%，女性参与者占15.1%。25%的被调查参与者知晓阴道微生态制剂，只有3%正确提及了一种用于预防HIV的阴道微生态制剂实例。参与者参与阴道微生态制剂试验合作的意愿与他们对阴道微生态制剂的了解没有显著相关性（p = 0.475）。
我们得出结论，尼日利亚妇科医生目前对阴道微生态制剂的了解较差。需要努力提高这些女性健康倡导者对最新HIV预防技术，特别是阴道微生态制剂的认识。
